|Bid||0.00 x 800|
|Ask||0.00 x 1800|
|Day's Range||66.75 - 67.96|
|52 Week Range||56.56 - 73.34|
|Beta (5Y Monthly)||0.42|
|PE Ratio (TTM)||16.57|
|Earnings Date||Oct 28, 2021|
|Forward Dividend & Yield||2.84 (4.22%)|
|Ex-Dividend Date||Sep 14, 2021|
|1y Target Est||76.03|
Subscribe to Yahoo Finance Plus to view Fair Value for GILDLearn more
Investors will focus on the HIV franchise's performance and Veklury sales in Gilead's (GILD) third-quarter 2021 results.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
If you're investing in a dividend stock, it's important to balance yield with risk. While you don't want to be too aggressive by looking for 10% dividend yields, you don't want to settle for nominal payouts either. Two stocks that pay at least 3% and are fairly safe buys over the long haul are Gilead Sciences (NASDAQ: GILD) and Campbell Soup (NYSE: CPB).